{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:28:31Z","timestamp":1761863311296,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.carrev.2014.04.005","type":"journal-article","created":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T13:30:27Z","timestamp":1398864627000},"page":"308-310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Single antiplatelet therapy after percutaneous coronary intervention in patients allergic to aspirin"],"prefix":"10.1016","volume":"15","author":[{"given":"Sanjeev Kumar","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2014.04.005_bb0005","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent anticoagulation restenosis study investigators","volume":"339","author":"Leon","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2014.04.005_bb0010","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2014.04.005_bb0015","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1253\/circj.CJ-10-0347","article-title":"Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (duration of dual antiplatelet therapy after implantation of endeavor stent) registry","volume":"74","author":"Hahn","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2014.04.005_bb0020","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","article-title":"A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (Real safety and efficacy of 3-month dual antiplatelet therapy following endeavor zotarolimus-eluting stent implantation)","volume":"60","author":"Kim","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.04.005_bb0025","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/eurheartj\/ehp105","article-title":"Aspirin following PCI: too much of a good thing?","volume":"30","author":"Steinhubl","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2014.04.005_bb0030","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1093\/eurheartj\/eht287","article-title":"Is aspirin useful in primary prevention?","volume":"34","author":"Cleland","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2014.04.005_bb0035","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2014.04.005_bb0040","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jacc.2007.10.040","article-title":"Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point","volume":"51","author":"Ndrepepa","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.04.005_bb0045","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1136\/bmj.321.7270.1183","article-title":"Risk of gastrointestinal haemorrhage with long term use of aspirin: a meta-analysis","volume":"321","author":"Derry","year":"2000","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.carrev.2014.04.005_bb0050","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/B:THRO.0000024050.78728.35","article-title":"Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation","volume":"16","author":"Newby","year":"2003","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.carrev.2014.04.005_bb0055","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2014.04.005_bb0060","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJM198806303182603","article-title":"Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty","volume":"318","author":"Schwartz","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2014.04.005_bb0065","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1161\/01.CIR.92.11.3194","article-title":"Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-hospital eastern Atlantic restenosis trial (M-HEART II)","volume":"92","author":"Savage","year":"1995","journal-title":"Circulation"},{"issue":"9431","key":"10.1016\/j.carrev.2014.04.005_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2014.04.005_bb0075","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1161\/CIRCULATIONAHA.108.813667","article-title":"Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents","volume":"119","author":"Eisenberg","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.04.005_bb0080","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2014.04.005_bb0085","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2008.12.055","article-title":"Predictors of coronary stent thrombosis: the Dutch stent thrombosis registry","volume":"53","author":"Van Werkum","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.04.005_bb0090","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jacc.2010.03.100","article-title":"Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (platelet inhibition and patient outcomes) PLATELET substudy","volume":"56","author":"Storey","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.04.005_bb0095","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2010.09.050","article-title":"High versus standard clopidogrel maintenance dose after percutaneous coronary intervention and effects on platelet inhibition, endothelial function, and inflammation","volume":"57","author":"Patti","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2014.04.005_bb0100","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.carrev.2014.04.005_bb0105","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention. The GRAVITAS randomized trial.","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.carrev.2014.04.005_bb0110","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jama.2011.1332","article-title":"High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI","volume":"306","author":"Parodi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2014.04.005_bb0115","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jacc.2013.05.022","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"62","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.carrev.2014.04.005_bb0125","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijcard.2012.03.052","article-title":"Antiplatelet therapy after genous EPC-capturing coronary stent implantation: the ARGENTO Study: a prospective, multicenter registry","volume":"167","author":"Cassese","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.carrev.2014.04.005_bb0130","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jcin.2009.10.006","article-title":"Evaluation in 3months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial","volume":"2","author":"Kim","year":"2009","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2014.04.005_bb0135","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/eurheartj\/ehl413","article-title":"Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography","volume":"28","author":"Matsumoto","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2014.04.005_bb0140","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0140-6736(12)62177-1","article-title":"Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial","volume":"381","author":"Dewilde","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.carrev.2014.04.005_bb0145","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/01.CIR.0000134306.28561.2A","article-title":"Approach to \u201caspirin allergy\u201d in cardiovascular patients","volume":"110","author":"Ramanuja","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.04.005_bb0150","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1093\/eurheartj\/ehn287","article-title":"A randomized study assessing the impact of cilostazol on platelet function profiles in patients with diabetes mellitus and coronary artery disease on dual antiplatelet therapy: results of the OPTIMUS-2 study","volume":"29","author":"Angiolillo","year":"2008","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:09:26Z","timestamp":1761559766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838914001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1553838914001328"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2014.04.005","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single antiplatelet therapy after percutaneous coronary intervention in patients allergic to aspirin","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2014.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}